July 19th 2024
Wearables have great potential to continue advancing research in Rett syndrome as well as other rare disease areas.
June 3rd 2024
How artificial intelligence can aid in selecting patients, leveraging safety insights, and optimizing combination therapies.
May 21st 2024
Despite limitations to its widespread use within healthcare, there is great potential for ChatGPT’s application in drug development.
May 17th 2024
Panna Sharma, CEO of Lantern Pharma, discusses LP-284, using their RADR during testing, ensuring global use, and what the future holds.
May 9th 2024
A survey conducted at this year’s Pistoia Alliance conference determined that although 70% of life sciences experts acknowledge artificial intelligence’s potential, many still struggle with its initiation and implementation.
AI in Clinical Trials: The Future of Drug Discovery
Despite the significance offered by AI to pharmaceutical companies, there are several challenges that must be overcome for successful integration of tech-based tools.